Click a link below to view the mailing archive as if it had been sent to you.
| 2015-09-30 12:15 | | Citing cost, top doctors back limits on PCSK9 cholesterol fighters and more... |
| 2015-09-30 00:15 | | Five Biotech Stocks That Could Be M&A Targets After the Selloff and more... |
| 2015-09-29 12:15 | | Contrave script growth snags, despite Takeda's 900-strong salesforce and more... |
| 2015-09-29 00:15 | | Note to Depomed shareholders: Let Horizon call its meetings, ISS advises and more... |
| 2015-09-28 12:15 | | Epilepsy device developer NeuroSigma withdraws IPO and more... |
| 2015-09-28 00:15 | | Roche says new drug shows benefits in lung, bladder cancer tests and more... |
| 2015-09-26 12:15 | | How the Top Biotechs Handled the Valuation Shock and more... |
| 2015-09-26 00:15 | | Biotech Bombs, Suffers Worst Weekly Decline Since ’08 and more... |
| 2015-09-25 12:15 | | Troubled GlaxoSmithKline to shutter R&D facility in France and more... |
| 2015-09-25 00:15 | | Bellerophon shares skyrocket on high blood pressure drug study and more... |
| 2015-09-24 12:15 | | Arrowhead Hits Target In Hepatitis B Drug Trial and more... |
| 2015-09-24 00:15 | | Here are the 5 drug classes with the biggest price gains and more... |
| 2015-09-23 12:15 | | New Turing CCO steps down amid drug price controversy and more... |
| 2015-09-23 00:15 | | Otsuka wins early FDA approval for a colorectal cancer combo drug and more... |
| 2015-09-22 12:15 | | Mass. police chief lists big pharma CEO phone numbers as part of opioid addiction fight and more... |
| 2015-09-22 00:15 | | Why Sequenom Slid More Than 15% Today and more... |
| 2015-09-21 12:15 | | 2nd time's the charm for Allergan, Richter antipsychotic drug and more... |
| 2015-09-21 00:15 | | Biotech CEO: Bass exploiting weakness in system and more... |
| 2015-09-20 00:15 | | Top 6 Biotech Movers From The Past Week and more... |
| 2015-09-19 12:15 | | Positive Topline Results Announced From Phase I/II Trial in Sanfilippo B Syndrome Patients Using uniQure's Novel AAV5-Based Gene Therapy and more... |
| 2015-09-19 00:15 | | Invuity touts data from device-assisted mastectomy study and more... |
| 2015-09-18 12:15 | | An update on first-ever US biosim Zarxio 2 weeks after its debut and more... |
| 2015-09-18 00:15 | | Lilly shares rally to near 15-year high on diabetes drug study results and more... |
| 2015-09-17 12:15 | | Amgen's Acquisition Of Dezima And CETP Drug Like Pfizer's '03 Buy Of Esperion. Will History Repeat? and more... |
| 2015-09-17 00:15 | | What It's Like To Have Dinner With BioMarin Executives and more... |
| 2015-09-16 12:15 | | Pharma Deal-Making: In The Pink Of Health and more... |
| 2015-09-16 00:15 | | Endo's Qualitest recalls blood pressure, gout drugs and more... |
| 2015-09-15 12:15 | | Raptor Pharmaceutical's Trial Failed, But Huntington's Disease Update Could Bring Gains At Year End and more... |
| 2015-09-15 00:15 | | Mylan-Perrigo Buyout Offer: What's Next? and more... |
| 2015-09-14 12:15 | | Diabetes rivalries get more complicated with new FDA warning on J&J's Invokana and more... |
| 2015-09-13 12:15 | | Could Major Acquisition Boost Gilead? and more... |
| 2015-09-13 00:15 | | Big Pharma's 3 Most Perilous Pipelines and more... |
| 2015-09-12 00:15 | | Incyte Hits High On Cancer Drug Data, Buyout Talk and more... |
| 2015-09-11 12:15 | | AstraZeneca picks up discarded Amgen plant as part of its biologics expansion and more... |
| 2015-09-11 00:15 | | AbbVie Posts Another Win for Humira and more... |
| 2015-09-10 12:15 | | Gilead Sciences Ready To Face Complera Patent War With Mylan and more... |
| 2015-09-10 00:15 | | Independent group finds new cholesterol drugs far too costly and more... |
| 2015-09-09 12:15 | | Merck and Samsung notch their first biosimilar victory with Enbrel knockoff and more... |
| 2015-09-09 00:15 | | J&J heads to Toronto with incubation plans for up to 50 upstart biotechs and more... |
| 2015-09-08 12:15 | | Horizon takes hostile Depomed bid directly to shareholders and more... |
| 2015-09-07 12:15 | | PCSK9 Inhibitor Therapies Face Pricing Pressures and more... |
| 2015-09-05 12:15 | | Novartis CEO says diabetics' contact lens tests to start in 2016 -paper and more... |
| 2015-09-04 12:15 | | Roche haemophilia drug wins fast-track FDA designation and more... |
| 2015-09-04 00:15 | | Velvet Ropes Can’t Stop the FDA: Effort to Defeat FDA Jurisdiction Based on Club Membership Is Unceremoniously Bounced and more... |
| 2015-09-03 12:15 | | The key facts to know about the FDA's new 340B drug discount guidance and more... |
| 2015-09-03 00:15 | | Lannett Buys UCB's U.S. Generics Division for $1.23 Billion and more... |
| 2015-09-02 12:15 | | Jardiance and its CV data? They're no knockout punch for stalwart Januvia, Merck says and more... |
| 2015-09-02 00:15 | | Will Bristol-Myers (BMY) Stock Be Helped by Myeloma Gaining FDA Priority Review Approval? and more... |
| 2015-09-01 12:15 | | AstraZeneca auctions off troubled psoriasis drug to Valeant in $445M deal and more... |
| 2015-09-01 00:15 | | Pharma sales forces should act more like 'outcomes advocates' and more... |
